Rx Marketing Compliance Programs “Ramping Up” After TAP – Prosecutor

Pharmaceutical manufacturers appear to be taking marketing compliance programs more seriously following the TAP settlement, Philadelphia Assistant U.S. Attorney James Sheehan told a Health Care Compliance Association teleconference Dec. 14